Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
11.41
+0.96 (+9.19%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cybin Inc
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Psychedelic Stock Gainers And Losers From April 18, 2022
April 18, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.66% at $0.28
Via
Benzinga
Cybin (NEO: CYBN) (NYSE American: CYBN) CEO Featured in Latest Power Play Release
April 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 14, 2022
April 14, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 2.50% at $5.32
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 13, 2022
April 13, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 19.41% at $0.24
Via
Benzinga
Cybin's (NYSE American: CYBN) (NEO: CYBN) CYB004 Demonstrates Advantages in Study
April 13, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Cybin's CYB0004 Shows Positive Preclinical Results Over Traditional Psychedelics
April 13, 2022
CYB004 is one of Cybin’s (NYSE: CYBN) proprietary second-generation psychedelics, developed to treat depression, anxiety, and ...
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2022
April 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 4.52% at $0.17
Via
Benzinga
Performance Comparisons Of The 5 Cannabis Sector Categories
April 10, 2022
Here is a summary of how each of the 5 categories in the cannabis sector performed over four time periods, to highlight the different category trends that are underway.
Via
Talk Markets
Revive Therapeutics, Cybin Among Top Psychedelic Movers Of Today
April 08, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.54% at $0.16
Via
Benzinga
WIPO Publishes Cybin's Patent Application For Inhaled Psychedelics Therapies
April 08, 2022
Cybin Inc. (NYSE: CYBN) announced that the World Intellectual Property Organization (WIPO) published an international patent ...
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Strengthens IP Position Of Psychedelic Programs
April 08, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Revive Therapeutics, Field Trip Health Among Top Psychedelic Movers Of Today
April 07, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.48% at $0.14
Via
Benzinga
Cybi (NEO: CYBN) (NYSE American: CYBN) To Participate In Benzinga Psychedelics Conference
April 07, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
April 06, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 4.78% at $19.73 LOSERS:
Via
Benzinga
A Builder From The Ground Up, Doug Drysdale, CEO of Cybin: Meet Our Speakers
April 06, 2022
From his beginnings at DuPont Merck to his current position as Cybin’s (NYSE: CYBN) CEO, Doug Drysdale has certainly had an ...
Via
Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 5, 2022
April 05, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 1.60% at $1.27 LOSERS:
Via
Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
April 04, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.06% at $14.18
Via
Benzinga
Cybin's (NYSE American: CYBN) (NEO: CYBN) Adelia Therapeutics Achieves New Milestone
April 04, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
3 Psychedelic Stocks to Buy for Oregon’s Magic Mushroom Bill
April 04, 2022
Psychedelic medical treatments and therapies are gaining in popularity, and these psychedelic stocks could benefit as the market emerges.
Via
InvestorPlace
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
April 01, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.26% at $0.86
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Commencement Of Kernel Flow(R) Study
April 01, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19%
April 01, 2022
An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the...
Via
Talk Markets
Field Trip Health, Revive Therapeutics Among Top Psychedelic Movers Of Today
March 31, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 3.38% at $0.27
Via
Benzinga
Cybin Begins Study Using Kernel Flow Headsets To Measure Ketamine's Effects On The Brain
March 31, 2022
The first study visit to measurethe psychedelic effects of ketamine in the cerebral cortex blood flowis underway, ...
Via
Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
March 30, 2022
GAINERS: Mindset Pharma (OTC:MSSTF) shares closed up 4.22% at $0.46
Via
Benzinga
Cybin (NYSE American: CYBN) (NEO: CYBN) Announces Milestone In CYB003 Program
March 30, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 29, 2022
March 29, 2022
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 9.05% at $5.42
Via
Benzinga
Cybin Completes In Vivo Preclinical Studies For Major Depressive Disorder
March 29, 2022
Cybin Inc.(NYSE: CYBN) announced that its in vivo preclinical studies evaluating the proprietary drug CYB003 are completed. ...
Via
Benzinga
Mindset Pharma, Small Pharma Among Top Psychedelic Movers Of Today
March 28, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 8.24% at $0.18
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.